Lb Montejano
Thomson Reuters
Publications 20
#1T. Kim Le (Eli Lilly and Company)H-Index: 2
#2Lb Montejano (Thomson Reuters)H-Index: 7
Last.Dennis C. Ang (IU: Indiana University)H-Index: 20
view all 5 authors...
Background: Osteoarthritis is a chronic debilitating condition affecting many adults in the United States. This study was to compare pharmacologic treatments and costs for newly diagnosed and existing osteoarthritis patients to assess unmet medication treatment needs and economic burden. Methods: This retrospective analysis of de-identified medical and pharmacy insurance claims from the MarketScan® databases identified adult patients with an osteoarthritis claim in 2007. The date of the first os...
22 CitationsSource
#1M. Bernauer (Eli Lilly and Company)
#2A. Farr (Thomson Reuters)H-Index: 1
Last.D. Kelsey (Eli Lilly and Company)
view all 7 authors...
#1T. Kim LeH-Index: 2
#2Lb MontejanoH-Index: 7
Last.Dennis C. AngH-Index: 20
view all 5 authors...
Background Osteoarthritis is a chronic and costly condition affecting 14% of adults in the US, and has a significant impact on patient quality of life. This retrospective cohort study compared direct health care utilization and costs between patients with osteoarthritis and a matched control group without osteoarthritis.
45 CitationsSource
#1Lb Montejano (Thomson Reuters)H-Index: 7
#2Rahul Sasané (Shire plc)H-Index: 11
Last.Daniel M. Huse (Thomson Reuters)H-Index: 5
view all 5 authors...
AbstractObjective:The burden of attention-deficit/hyperactivity disorder (ADHD) in adults is increasingly recognized. This retrospective analysis was designed to estimate the prevalence of diagnosed ADHD in a population of insured, employed individuals and their dependents in the United States.Methods:Health care claims data obtained from the MarketScan Commercial Claims and Encounters Database were analyzed. Patients with ADHD were identified by at least two diagnostic claims per calendar year....
30 CitationsSource
#1S.L. Slabaugh (Janssen Pharmaceutica)
#2M. Durkin (Janssen Pharmaceutica)H-Index: 1
Last.Lb Montejano (Thomson Reuters)H-Index: 7
view all 3 authors...
#1T.K. Le (Eli Lilly and Company)H-Index: 1
#2Lb Montejano (Thomson Reuters)H-Index: 7
Last.D. Ang (IU: Indiana University)
view all 5 authors...
Attention-deficit/hyperactivity disorder (ADHD) is typically characterized as a childhood disease; however, there is increasing recognition of the burden the disorder places on adults.1,2 It has been estimated that 50%–75% of children with ADHD continue to meet criteria for ADHD as adolescents and adults,3 that 80% of children with ADHD continue to be symptomatic in adolescence,4 and that 7.0% of children and 4.4% of adults in the United States are affected by the disorder.5,6 Similar results we...
10 CitationsSource
Attention-deficit/hyperactivity disorder (ADHD) is a neurobehavioral condition characterized by core symptoms of inattentiveness, hyperactivity, and impulsivity that can manifest as disruptions in the academic, social, and home settings.1 Although once considered to be a childhood disorder, there is a growing recognition of the persistence of ADHD into adulthood and the need for treatment.2–10 The 12-month prevalence of adults with ADHD in the United States has been estimated to be 4.4%,11 makin...
40 CitationsSource
#1Lb Montejano (Thomson Reuters)H-Index: 7
#2T. Le (Thomson Reuters)
Last.D. Ang (Thomson Reuters)
view all 5 authors...
#1Rebecca RobinsonH-Index: 1
#2Lb MontejanoH-Index: 7
Last.Greg LenhartH-Index: 5
view all 4 authors...
INTRODUCTION AND OBJECTIVES: Interstitial cystitis (IC) and painful bladder syndrome (PBS) are related conditions, affecting 1–17% of women and 0.25–5% percent of men (Clemens et al. J Urol 2005; Clemens et al. J Urol 2007; Ibrahim et al. Int Urol Nephrol 2007). Many people with IC/PBS symptoms do not seek treatment, but previous research suggests IC/PBS healthcare costs are significant. This study was undertaken to identify costs and cost drivers associated with IC/PBS. METHODS: Adult patients ...
1 CitationsSource